General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0RFWQY
ADC Name
ADRX-0706
Synonyms
ADRX 0706; ADRX-0706; ADRX0706
   Click to Show/Hide
Organization
Adcentrx Therapeutics, Inc.
Drug Status
Phase 1
Indication
In total 4 Indication(s)
Breast cancer
Phase 1
Clinical Trial
Cervical cancer
Phase 1
Clinical Trial
Solid tumor
Phase 1
Clinical Trial
Urothelial cancer
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
8
Antibody Name
Undisclosed
Antigen Name
Nectin-4 (NECTIN4)
 Antigen Info 
Payload Name
AP052
 Payload Info 
Therapeutic Target
Microtubule (MT)
 Target Info 
Conjugate Type
Undisclosed